IRCT20150107020592N30招募中3 期
Favipiravir prophylactic to reduce the involvement of health care workers in the COVID-19 epidemic
Vice chancellor for research, Shahid Beheshti university of medical sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 no limit（—）
- 性别
- All
入选标准
- •Age over 20 years
- •Nurses in the intensive care unit
- •Satisfaction with entering the plan
排除标准
- •Sensitivity to antiviral drugs
研究者
相似试验
已完成
不适用
flunarizine therapy in reducing vertigo symptoms among patients with vestibular migraine.CTRI/2019/09/021185Farnaz Nasrin ISlam31
已完成
不适用
Investigation on the effect of favipiravir in preventing Ebola virus disease and its safetyEbola virus diseaseJPRN-UMIN000016102ational Center for Global Health and Medicine25
已完成
3 期
Randomized Trial to Prevent Vascular Events in HIV - REPRIEVECTRI/2017/08/009558IH DAIDS250
尚未招募
2 期
Post-Exposure Prophylaxis with Favipiravir among Household Close Contacts to Confirmed COVID-19 cases: Cluster-Randomized TrialHousehold contacts with SARS-CoV-2 index caseFavipiravir, post-exposure prophylaxis, household, Favipiravir solution, COVID-19, SARS-CoV-2TCTR20210909002Chulabhorn Royal Academy156
尚未招募
不适用
Clinical trial on prevention as well as reduction of chemotherapy-induced neuropathy with acupuncture treatment on the breast cancer patientsChemotherapy-induced peripheral neuropathyITMCTR2200006866Jiangsu Provincial Hospital of Traditional Chinese Medicine